-
1
-
-
0030975760
-
The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients
-
Knoll GA, Tankerslev MR, Lee JT, et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis. 1997; 29: 608-614.
-
(1997)
Am J Kidney Dis
, vol.29
, pp. 608-614
-
-
Knoll, G.A.1
Tankerslev, M.R.2
Lee, J.T.3
-
2
-
-
0032065536
-
Effect of hepatitis C infection and renal transplantation on survival in end state renal disease
-
Pereira BJ, Natov SN, Bouthot BA, et al. Effect of hepatitis C infection and renal transplantation on survival in end state renal disease. Kidney Int. 1998; 53: 1374-1381.
-
(1998)
Kidney Int
, vol.53
, pp. 1374-1381
-
-
Pereira, B.J.1
Natov, S.N.2
Bouthot, B.A.3
-
3
-
-
11844251216
-
Outcome of hepatitis C virus infected kidney transplant candidates who remain on the waiting list
-
Bloom RD, Sayer G, Fa K, et al. Outcome of hepatitis C virus infected kidney transplant candidates who remain on the waiting list.AmJ Transplant. 2005; 5: 139-144.
-
(2005)
AmJ Transplant
, vol.5
, pp. 139-144
-
-
Bloom, R.D.1
Sayer, G.2
Fa, K.3
-
4
-
-
79957698663
-
Effect of kidney transplantation on outcomes among patients with hepatitis C
-
Roth D, Gaynor JJ, Reddy RK, et al. Effect of kidney transplantation on outcomes among patients with hepatitis C. J Am Soc Nephrol. 2011; 22: 1152-1160.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1152-1160
-
-
Roth, D.1
Gaynor, J.J.2
Reddy, R.K.3
-
5
-
-
4544288377
-
Epidemiology and clinical significance of hepatotropic infections in dialysis patients
-
Fabrizi F, Bunnapradist S, Lunghi G, et al. Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Minerva Urol Nefrol. 2004; 56: 249-257.
-
(2004)
Minerva Urol Nefrol
, vol.56
, pp. 249-257
-
-
Fabrizi, F.1
Bunnapradist, S.2
Lunghi, G.3
-
6
-
-
0035154906
-
Serumalanine aminotransferase in hepatitis C screening of patients on hemodialysis
-
Saab S, Martin P, BrezinaM, et al. Serumalanine aminotransferase in hepatitis C screening of patients on hemodialysis. Am J Kidney Dis. 2001; 37: 308-315.
-
(2001)
Am J Kidney Dis
, vol.37
, pp. 308-315
-
-
Saab, S.1
Martin, P.2
Brezina, M.3
-
7
-
-
0033783124
-
The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands
-
Schneeberger PM, Keur I, van Loon AM, et al. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands. J Infect Dis. 2000; 182: 1291-1299.
-
(2000)
J Infect Dis
, vol.182
, pp. 1291-1299
-
-
Schneeberger, P.M.1
Keur, I.2
Van Loon, A.M.3
-
8
-
-
2442642562
-
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS
-
Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004; 65: 2335-2342.
-
(2004)
Kidney Int
, vol.65
, pp. 2335-2342
-
-
Fissell, R.B.1
Bragg-Gresham, J.L.2
Woods, J.D.3
-
9
-
-
74549158417
-
KDIGO Guideline 4: Management of HCV-infected patients before and after kidney transplantation
-
KDIGO Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney Int. 2008; 73: S53-S68.
-
(2008)
Kidney Int
, vol.73
, pp. S53-S68
-
-
-
10
-
-
0031916989
-
Acquisition of hepatitis C virus in hemodialysis patients: A prospective study by branched DNA signal amplification assay
-
Fabrizi F, Martin P, Dixit V, et al. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am J Kidney Dis. 1998; 31: 647-654.
-
(1998)
Am J Kidney Dis
, vol.31
, pp. 647-654
-
-
Fabrizi, F.1
Martin, P.2
Dixit, V.3
-
11
-
-
0037219481
-
Progression of fibrosis in chronic hepatitis C
-
Ghany MG, Kleiner DE, Alter H, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology. 2003; 124: 97-104.
-
(2003)
Gastroenterology
, vol.124
, pp. 97-104
-
-
Ghany, M.G.1
Kleiner, D.E.2
Alter, H.3
-
12
-
-
0029778988
-
An algorithm for the grading of activity in chronic hepatitis C
-
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996; 24: 289-293.
-
(1996)
Hepatology
, vol.24
, pp. 289-293
-
-
Bedossa, P.1
Poynard, T.2
-
13
-
-
84924543106
-
Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment
-
Kim JH, Kim MN, Kim SU. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment. Liver Int. 2015; 35: 1103-1115.
-
(2015)
Liver Int
, vol.35
, pp. 1103-1115
-
-
Kim, J.H.1
Kim, M.N.2
Kim, S.U.3
-
14
-
-
84984572895
-
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
-
Liu CH, Liang CC, Huang KW, et al. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol. 2011; 6: 1057-1065.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 1057-1065
-
-
Liu, C.H.1
Liang, C.C.2
Huang, K.W.3
-
15
-
-
68949215046
-
Correlation between fibroscan, liver biopsy, and clinical liver function in patients with hepatitis C virus infection after renal transplantation
-
Munoz R, Ramirez E, Fernandez I, et al. Correlation between fibroscan, liver biopsy, and clinical liver function in patients with hepatitis C virus infection after renal transplantation. Transplant Proc. 2009; 41: 2425-2426.
-
(2009)
Transplant Proc.
, vol.41
, pp. 2425-2426
-
-
Munoz, R.1
Ramirez, E.2
Fernandez, I.3
-
16
-
-
75349114937
-
Liver stiffness is directly influenced by central venous pressure
-
Milonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010; 52: 206-210.
-
(2010)
J Hepatol
, vol.52
, pp. 206-210
-
-
Milonig, G.1
Friedrich, S.2
Adolf, S.3
-
17
-
-
0034527808
-
Liver damage in hemodialysis patients with hepatitis C virus viremia: A prospective 10 year study
-
Furusyo N, Hayashi J, Kanamoto-Tanaka Y, et al. Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10 year study. Dig Dis Sci. 2000; 45: 2221-2228.
-
(2000)
Dig Dis Sci
, vol.45
, pp. 2221-2228
-
-
Furusyo, N.1
Hayashi, J.2
Kanamoto-Tanaka, Y.3
-
18
-
-
0027423952
-
Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus
-
Carmelo C, Ortiz A, Aguilera B, et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis. 1993; 22: 822-828.
-
(1993)
Am J Kidney Dis
, vol.22
, pp. 822-828
-
-
Carmelo, C.1
Ortiz, A.2
Aguilera, B.3
-
19
-
-
0027504601
-
Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications
-
Pol S, Romeo R, Zins B, et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int. 1996; 44: 1097-1100.
-
(1996)
Kidney Int
, vol.44
, pp. 1097-1100
-
-
Pol, S.1
Romeo, R.2
Zins, B.3
-
20
-
-
0033697444
-
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: Comparison of hepatic histology and response to interferon therapy
-
Shiffman M, Stewart C, Hofmann C, et al. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy. J Infect Dis. 2000; 182: 1595-1601.
-
(2000)
J Infect Dis
, vol.182
, pp. 1595-1601
-
-
Shiffman, M.1
Stewart, C.2
Hofmann, C.3
-
21
-
-
0032919671
-
Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients
-
Glicklich D, Thung SN, Kapoian T, et al. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol. 1999; 94: 159-163.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 159-163
-
-
Glicklich, D.1
Thung, S.N.2
Kapoian, T.3
-
22
-
-
0036020435
-
Characteristics of hepatitis C in renal transplant candidates
-
Cotler SJ, Diaz G, Gundlapalli S. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol. 2000; 35: 191-195.
-
(2000)
J Clin Gastroenterol
, vol.35
, pp. 191-195
-
-
Cotler, S.J.1
Diaz, G.2
Gundlapalli, S.3
-
23
-
-
0032787332
-
Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renal transplantation
-
Sterling RK, Sanyal AJ, Luketic VA, et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol. 1999; 94: 3576-3582.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 3576-3582
-
-
Sterling, R.K.1
Sanyal, A.J.2
Luketic, V.A.3
-
24
-
-
0034656075
-
Histopathological features of hepatitis C in renal transplant candidates
-
Martin P, Carter D, Fabrizi F, et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation. 2000; 69: 1479-1484.
-
(2000)
Transplantation
, vol.69
, pp. 1479-1484
-
-
Martin, P.1
Carter, D.2
Fabrizi, F.3
-
26
-
-
53749099347
-
Proceedings of consensus conference on simultaneous liver kidney transplantation
-
Eason JD, Gonwa TA, Davis CL, et al. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation. Am J Transplant. 2008; 8: 2243-2251.
-
(2008)
Am J Transplant
, vol.8
, pp. 2243-2251
-
-
Eason, J.D.1
Gonwa, T.A.2
Davis, C.L.3
-
27
-
-
0031754266
-
Risk of death among chronic dialysis patients infected with hepatitis C virus
-
Stehman-Breen CO, Emerson S, Gretch D, et al. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis. 1998; 32: 629-6354.
-
(1998)
Am J Kidney Dis
, vol.32
, pp. 629-6354
-
-
Stehman-Breen, C.O.1
Emerson, S.2
Gretch, D.3
-
29
-
-
34548673072
-
The impact of hepatitis C virus infection on survival in dialysis patients: Meta-analysis of observational studies
-
Fabrizi F, Takkouche B, Lunghi G, et al. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007; 14: 697-703.
-
(2007)
J Viral Hepat
, vol.14
, pp. 697-703
-
-
Fabrizi, F.1
Takkouche, B.2
Lunghi, G.3
-
30
-
-
4644251292
-
Renal Transplantation offers a better survival in HCV-infected ESRD patients
-
Szer S, Ozdemir FN, Akcay A, et al. Renal Transplantation offers a better survival in HCV-infected ESRD patients. Clin Transplant. 2004; 18: 619-623.
-
(2004)
Clin Transplant
, vol.18
, pp. 619-623
-
-
Szer, S.1
Ozdemir, F.N.2
Akcay, A.3
-
31
-
-
0029887721
-
A prospective study of hepatitis C virus infection in renal allograft recipients
-
Roth D, Zucker K, Cirocco R, et al. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation. 1996; 61: 886-889.
-
(1996)
Transplantation
, vol.61
, pp. 886-889
-
-
Roth, D.1
Zucker, K.2
Cirocco, R.3
-
32
-
-
0028786172
-
The impact of pretransplantation hepatitis c infection on the outcome of renal transplantation
-
Pereira BJ, Wright TL, Schmid CH, et al. The impact of pretransplantation hepatitis c infection on the outcome of renal transplantation. Transplantation. 1995; 60: 799-805.
-
(1995)
Transplantation
, vol.60
, pp. 799-805
-
-
Pereira, B.J.1
Wright, T.L.2
Schmid, C.H.3
-
33
-
-
78650307256
-
Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand
-
Scott DR, Wong JK, Spicer TS, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation. 2010; 90: 1165-1171.
-
(2010)
Transplantation
, vol.90
, pp. 1165-1171
-
-
Scott, D.R.1
Wong, J.K.2
Spicer, T.S.3
-
34
-
-
80052394261
-
Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA/REIPI Cohort
-
Lopez-Medrano F, Fernandez-Ruiz M, Morales JM, et al. Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: data from the RESITRA/REIPI Cohort. Transplantation. 2011; 92: 543-549.
-
(2011)
Transplantation
, vol.92
, pp. 543-549
-
-
Lopez-Medrano, F.1
Fernandez-Ruiz, M.2
Morales, J.M.3
-
35
-
-
0032951872
-
Impact of hepatitis B and C virus on kidney transplantation outcome
-
Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology. 1999; 29: 257-263.
-
(1999)
Hepatology
, vol.29
, pp. 257-263
-
-
Mathurin, P.1
Mouquet, C.2
Poynard, T.3
-
36
-
-
0036146582
-
Severe evolution of chronic hepatitis C in renal transplantation: A case control study
-
Zylberberg H, Nalpas B, Carnot F, et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant. 2002; 17: 129-133.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 129-133
-
-
Zylberberg, H.1
Nalpas, B.2
Carnot, F.3
-
37
-
-
84898420176
-
Meta-analysis of observational studies: Hepatitis C and survival after renal transplant
-
Fabrizi F, Martin P, Dixit V, et al. Meta-analysis of observational studies: hepatitis C and survival after renal transplant. J Viral Hepat. 2014; 21: 314-324.
-
(2014)
J Viral Hepat
, vol.21
, pp. 314-324
-
-
Fabrizi, F.1
Martin, P.2
Dixit, V.3
-
38
-
-
0034721110
-
Renal disease associated with hepatitis C infection after kidney and liver transplantation
-
Baid S, Cosmi AB, Tolkoff-Rubin N, et al. Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation. 2000; 70: 255-261.
-
(2000)
Transplantation
, vol.70
, pp. 255-261
-
-
Baid, S.1
Cosmi, A.B.2
Tolkoff-Rubin, N.3
-
39
-
-
80053505006
-
Overlapping pathways to transplant glomerulopathy: Chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy
-
Baid-Agrawal S, Farris AB 3rd, Pascual M, et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int. 2011; 80: 879-885.
-
(2011)
Kidney Int
, vol.80
, pp. 879-885
-
-
Baid-Agrawal, S.1
Farris, A.B.2
Pascual, M.3
-
40
-
-
0035401238
-
HepatitisCvirus infection anddenovo glomerular lesions in renal allografts
-
CruzadoJM, CarreraM, Torras J, et al. HepatitisCvirus infection anddenovo glomerular lesions in renal allografts. Am J Transplant. 2001; 1: 171-178.
-
(2001)
Am J Transplant
, vol.1
, pp. 171-178
-
-
Cruzado, J.M.1
Carrera, M.2
Torras, J.3
-
41
-
-
84856820955
-
Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation
-
Cruzado JM, Bestard O, Grinyo JM. Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation. Contrib Nephrol. 2012; 176: 108-116.
-
(2012)
Contrib Nephrol
, vol.176
, pp. 108-116
-
-
Cruzado, J.M.1
Bestard, O.2
Grinyo, J.M.3
-
42
-
-
0036232458
-
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus
-
Bloom RD, Rao V, Weng F, et al. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol. 2002; 13: 1374-1380.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1374-1380
-
-
Bloom, R.D.1
Rao, V.2
Weng, F.3
-
43
-
-
0037297155
-
Diabetes mellitus after kidney transplantation in the United States
-
Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003; 3: 178-185.
-
(2003)
Am J Transplant
, vol.3
, pp. 178-185
-
-
Kasiske, B.L.1
Snyder, J.J.2
Gilbertson, D.3
-
44
-
-
0037184347
-
Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients
-
Yildiz A, Tutuncu Y, Yazici H, et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation. 2002; 74: 1109-1113.
-
(2002)
Transplantation
, vol.74
, pp. 1109-1113
-
-
Yildiz, A.1
Tutuncu, Y.2
Yazici, H.3
-
45
-
-
9644303150
-
Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus
-
Abbott KC, Lentine KL, Bucci JR, et al. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol. 2004; 15: 3166-3174.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 3166-3174
-
-
Abbott, K.C.1
Lentine, K.L.2
Bucci, J.R.3
-
46
-
-
33748495612
-
Emerging issues in hepatitis C virus-positive liver and kidney recipients
-
Bloom RD, Lake JR. Emerging issues in hepatitis C virus-positive liver and kidney recipients. Am J Transplant. 2006; 6: 2232-2237.
-
(2006)
Am J Transplant
, vol.6
, pp. 2232-2237
-
-
Bloom, R.D.1
Lake, J.R.2
-
47
-
-
84857640535
-
Diabetes mellitus following liver transplantation in patients with hepatitis C virus: Risks and consequences
-
Gane EJ. Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences. Am J Transplant. 2012; 12: 531-538.
-
(2012)
Am J Transplant
, vol.12
, pp. 531-538
-
-
Gane, E.J.1
-
48
-
-
78549288927
-
Outcomes of kidney transplantation in HIV-infected recipients
-
[Erratum in: N Engl J Med. 2011, 17; 364(11) 1082]
-
Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl JMed. 2010; 363: 2004-2014 [Erratum in: N Engl J Med. 2011, 17; 364(11): 1082].
-
(2010)
N Engl JMed
, vol.363
, pp. 2004-2014
-
-
Stock, P.G.1
Barin, B.2
Murphy, B.3
-
49
-
-
84938531019
-
Superior outcomes in HIVpositive kidney transplant patients compared with HCV-infected or HIV/ HCV-coinfected recipients
-
Sawinski D, Forde KA, Eddinger K, et al. Superior outcomes in HIVpositive kidney transplant patients compared with HCV-infected or HIV/ HCV-coinfected recipients. Kidney Int. 2015; 88: 341-349.
-
(2015)
Kidney Int
, vol.88
, pp. 341-349
-
-
Sawinski, D.1
Forde, K.A.2
Eddinger, K.3
-
50
-
-
77956454888
-
Kidney grafts from HCV-positive donors: Advantages and disadvantages
-
Maluf DG, Archer KJ, Mas VR. Kidney grafts from HCV-positive donors: advantages and disadvantages. Transplant Proc. 2010; 42: 2436-2446.
-
(2010)
Transplant Proc.
, vol.42
, pp. 2436-2446
-
-
Maluf, D.G.1
Archer, K.J.2
Mas, V.R.3
-
51
-
-
78349282310
-
Long termexperience with kidney transplantation from Hepatitis C positive donors into hepatitis C positive recipients
-
Morales JM, Campistol JM, Dominguez-Gil B, et al. Long termexperience with kidney transplantation from Hepatitis C positive donors into hepatitis C positive recipients. Am J Transplant. 2010; 10: 2453-2462.
-
(2010)
Am J Transplant
, vol.10
, pp. 2453-2462
-
-
Morales, J.M.1
Campistol, J.M.2
Dominguez-Gil, B.3
-
52
-
-
0028794061
-
Recombinant alpha interferon in renal allograft recipients with chronic hepatitis C
-
Ozgur O, Boyacioglu S, Telatur H, et al. Recombinant alpha interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant. 1995; 10: 2104-2106.
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 2104-2106
-
-
Ozgur, O.1
Boyacioglu, S.2
Telatur, H.3
-
53
-
-
0029022845
-
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients
-
Rostaing L, Izopet J, Baron E, et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995; 59: 1426-1431.
-
(1995)
Transplantation
, vol.59
, pp. 1426-1431
-
-
Rostaing, L.1
Izopet, J.2
Baron, E.3
-
54
-
-
79959478969
-
Chronic hepatitisC infection
-
Rosen H. Chronic hepatitisC infection.NEnglJMed. 2011; 364: 2429-2438.
-
(2011)
NEnglJMed
, vol.364
, pp. 2429-2438
-
-
Rosen, H.1
-
55
-
-
0347694845
-
Meta analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients
-
Fabrizi F, Dulai G, Dixit V, et al.Meta analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003; 18: 1071-1081.
-
(2003)
Aliment Pharmacol Ther
, vol.18
, pp. 1071-1081
-
-
Fabrizi, F.1
Dulai, G.2
Dixit, V.3
-
56
-
-
0038119080
-
Interferon monotherapy for dialysis patient with chronic hepatitis C: An analysis of the literature on efficacy and safety
-
Russo MW, Goldsweig CD, Jacobsen IM, et al. Interferon monotherapy for dialysis patient with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol. 2003; 98: 1610-1615.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1610-1615
-
-
Russo, M.W.1
Goldsweig, C.D.2
Jacobsen, I.M.3
-
57
-
-
84906883176
-
Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: Meta-analysis of clinical studies
-
Fabrizi F, Dixit V, Messa P, et al. Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies. J Viral Hepat. 2014; 21: 681-689.
-
(2014)
J Viral Hepat
, vol.21
, pp. 681-689
-
-
Fabrizi, F.1
Dixit, V.2
Messa, P.3
-
58
-
-
84906874689
-
Hepatitis. Chronic HCV infection, diabetes and liverrelated outcomes
-
Henry L, Younossi Z. Hepatitis. Chronic HCV infection, diabetes and liverrelated outcomes. Nat Rev Gastroenterol Hepatol. 2014; 11: 520-521.
-
(2014)
Nat Rev Gastroenterol Hepatol
, vol.11
, pp. 520-521
-
-
Henry, L.1
Younossi, Z.2
-
59
-
-
84893768533
-
Cardiovascular disease and HCV infection: A simple association or more?
-
Petta S, Macaluso FS, Craxì A. Cardiovascular disease and HCV infection: a simple association or more? Gut. 2014; 63: 369-375.
-
(2014)
Gut
, vol.63
, pp. 369-375
-
-
Petta, S.1
Macaluso, F.S.2
Craxì, A.3
-
60
-
-
84886734901
-
Hepatitis C infection is very rarely treated among hemodialysis patients
-
Goodkin DA, Bieber B, Gillespie B, et al. Hepatitis C infection is very rarely treated among hemodialysis patients. Am J Nephrol. 2013; 38: 405-412.
-
(2013)
Am J Nephrol
, vol.38
, pp. 405-412
-
-
Goodkin, D.A.1
Bieber, B.2
Gillespie, B.3
-
61
-
-
0035049792
-
Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: Results after transplantation
-
Casanovas-Taltavull T, Baliellas C, Benasco C, et al. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol. 2001; 96: 1170-1177.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 1170-1177
-
-
Casanovas-Taltavull, T.1
Baliellas, C.2
Benasco, C.3
-
62
-
-
0042844701
-
Evidence that clearance of hepatitis C virus RNA after a-interferon therapy in dialysis patients is sustained after renal transplantation
-
Kamar N, Toupance O, Buchler M, et al. Evidence that clearance of hepatitis C virus RNA after a-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol. 2003; 14: 2092-2098.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2092-2098
-
-
Kamar, N.1
Toupance, O.2
Buchler, M.3
-
63
-
-
0037356479
-
Pretransplant interferon prevents hepatitis C virus associated glomerulonephritis in renal allografts by HCV-RNA clearance
-
Cruzado JM, Casanovas-Taltavull T, Torras J, et al. Pretransplant interferon prevents hepatitis C virus associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant. 2003; 3: 357-360.
-
(2003)
Am J Transplant
, vol.3
, pp. 357-360
-
-
Cruzado, J.M.1
Casanovas-Taltavull, T.2
Torras, J.3
-
64
-
-
0343238465
-
Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients
-
Gürsoy M, Güvener N, Köksal R, et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients. Transplant Proc. 2000; 32: 561-562.
-
(2000)
Transplant Proc.
, vol.32
, pp. 561-562
-
-
Gürsoy, M.1
Güvener, N.2
Köksal, R.3
-
65
-
-
12144287925
-
Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation
-
Delgado-Borrego A, Casson D, Schoenfeld D, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation. 2004; 77: 703-710.
-
(2004)
Transplantation
, vol.77
, pp. 703-710
-
-
Delgado-Borrego, A.1
Casson, D.2
Schoenfeld, D.3
-
66
-
-
0033950690
-
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha
-
Konrad T, Zeuzem S, Vicini P, et al. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha. Eur J Clin Invest. 2000; 30: 111-121.
-
(2000)
Eur J Clin Invest
, vol.30
, pp. 111-121
-
-
Konrad, T.1
Zeuzem, S.2
Vicini, P.3
-
67
-
-
84877753528
-
Current and future therapies for hepatitis C virus infection
-
Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl JMed. 2013; 368: 1907-1917.
-
(2013)
N Engl JMed
, vol.368
, pp. 1907-1917
-
-
Liang, T.J.1
Ghany, M.G.2
-
68
-
-
84911409020
-
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatmentnaive patients: The COSMOS randomised study
-
Lawitz E, Sulkowitz MS, Ghalib R, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatmentnaive patients: the COSMOS randomised study. Lancet. 2014; 384: 1756-1765.
-
(2014)
Lancet
, vol.384
, pp. 1756-1765
-
-
Lawitz, E.1
Sulkowitz, M.S.2
Ghalib, R.3
-
69
-
-
84877730954
-
Sofosbuvir for previously untreated chronic hepatitis C infection
-
Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl JMed. 2013; 368: 1878-1887.
-
(2013)
N Engl JMed
, vol.368
, pp. 1878-1887
-
-
Lawitz, E.1
Mangia, A.2
Wyles, D.3
-
70
-
-
84899970077
-
The rapid evolution of treatment strategies for hepatitis C
-
Muir AJ. The rapid evolution of treatment strategies for hepatitis C. Am J Gastroenterol. 2014; 109: 628-635.
-
(2014)
Am J Gastroenterol
, vol.109
, pp. 628-635
-
-
Muir, A.J.1
-
71
-
-
84919360641
-
An interferon-free antiviral regimen for HCV after liver transplantation
-
Kwo PY, Mantry PS, Coakley E, et al. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014; 371: 2375-2382.
-
(2014)
N Engl J Med
, vol.371
, pp. 2375-2382
-
-
Kwo, P.Y.1
Mantry, P.S.2
Coakley, E.3
-
72
-
-
0033857651
-
Effect of waiting time on renal transplant outcome
-
Meier Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int. 2000; 58: 1311-1317.
-
(2000)
Kidney Int
, vol.58
, pp. 1311-1317
-
-
Meier Kriesche, H.U.1
Port, F.K.2
Ojo, A.O.3
-
73
-
-
0142184903
-
Hepatitis C and renal transplantation in the era of modern immunosuppression
-
Abbott KC, Bucci JR, Matsumoto CS, et al. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol. 2003; 14: 2908-2918.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2908-2918
-
-
Abbott, K.C.1
Bucci, J.R.2
Matsumoto, C.S.3
-
74
-
-
0028826702
-
Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney
-
Widell A, Mansson S, Persson NH, et al. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation. 1995; 60: 642-647.
-
(1995)
Transplantation
, vol.60
, pp. 642-647
-
-
Widell, A.1
Mansson, S.2
Persson, N.H.3
-
75
-
-
84952352926
-
-
American Association for the Study of Liver Diseases/Infectious Disease Society of America Joint Guidelines, Recommendations for Testing, Managing, and Treating Hepatitis C, Unique Patient Populations: Patients with HIV/HCV co-infection (last modified April 9, 2015
-
American Association for the Study of Liver Diseases/Infectious Disease Society of America Joint Guidelines, Recommendations for Testing, Managing, and Treating Hepatitis C, Unique Patient Populations: Patients with HIV/HCV co-infection, http://www.hcvguidelines.org/fullreport/ unique-patientpopulations-patients-hivhcv-coinfection, (last modified April 9, 2015).
-
-
-
-
76
-
-
84928077350
-
Therapywith boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation
-
Antonini TM, Furlan V, Teicher E, et al. Therapywith boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. AIDS. 2015; 29: 53-58.
-
(2015)
AIDS
, vol.29
, pp. 53-58
-
-
Antonini, T.M.1
Furlan, V.2
Teicher, E.3
|